hydroxyl radical has been researched along with Parkinson Disease in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.65) | 18.7374 |
| 1990's | 21 (48.84) | 18.2507 |
| 2000's | 13 (30.23) | 29.6817 |
| 2010's | 5 (11.63) | 24.3611 |
| 2020's | 2 (4.65) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Fu, X; Wang, X; Xia, Q; Zhang, T; Zhong, L; Zhu, J | 1 |
| Cao, Z; Fu, X; Wang, X; Zhang, F; Zhang, T; Zhu, J | 1 |
| Deng, YL; Li, HM; Li, YJ; Meng, LY; Schläppi, M; Song, DW; Xie, BJ; Xin, N | 1 |
| Kell, DB | 1 |
| Gowda, B; Jaisankar, P; Mohanakumar, KP; Nagashayana, N; Sengupta, T; Vinayagam, J | 1 |
| Ashihara, E; Inden, M; Kitamura, Y; Takata, K; Yasui, H; Yoshimoto, K | 1 |
| Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Wardas, J | 1 |
| Kang, JH; Kim, KS | 1 |
| Brus, R; Kostrzewa, JP; Kostrzewa, RA; Kostrzewa, RM; Nowak, P | 1 |
| Galoyan, AA; Knaryan, VH; Mohanakumar, KP; Samantaray, S; Srinivasan, A; Varghese, M | 1 |
| Allsop, D; Benson, FE; El-Agnaf, OM; King, JE; Tabner, BJ; Turnbull, S | 1 |
| Deng, YL; Liu, XQ; Qing, H; Wang, R; Zheng, XL | 1 |
| Cohen, G | 2 |
| Lavie, L; Youdim, MB | 1 |
| Dostert, P; Maruyama, W; Matsubara, K; Naoi, M | 1 |
| Gutteridge, JM | 1 |
| Chiueh, CC; Mohanakumar, KP; Murphy, DL; Wu, RM | 1 |
| Chiueh, CC; Krishna, G; Mohanakumar, KP; Murphy, DL; Obata, T; Sternberger, LM; Wu, RM | 1 |
| Dykens, JA | 1 |
| Ben-Shachar, D; Eshel, G; Finberg, JP; Riederer, P; Youdim, MB | 1 |
| Fukushima, T; Hojo, N; Isobe, A; Shiwaku, K; Tawara, T; Yamane, Y | 1 |
| Kondo, T | 1 |
| Herlinger, E; Jellinger, K; Kienzl, E; Linert, L; Youdim, MB | 1 |
| Aruoma, OI; Butler, J; Dexter, DT; Halliwell, B; Jenner, A; Jenner, P; Spencer, JP | 1 |
| Hayakawa, M; Ikebe, S; Katsumata, K; Mizuno, Y; Ozawa, T; Yoneda, M | 1 |
| Alam, ZI; Cairns, N; Daniel, SE; Halliwell, B; Jenner, A; Jenner, P; Lees, AJ; Marsden, CD | 1 |
| Jiang, DH; Lan, J | 1 |
| Faucheux, BA; Hirsch, EC | 1 |
| Graham, DG; Montine, TJ; Olson, SJ; Perry, G; Robertson, D; Smith, MA; Zhang, J | 1 |
| Blandini, F; Desideri, S; Godi, L; Mancini, F; Martignoni, E; Nappi, G; Pacchetti, C | 1 |
| Cheng, FC; Dryhurst, G; Han, J; Yang, Z | 1 |
| Blandini, F; di Jeso, F; Martignoni, E; Nappi, G; Ricotti, R | 1 |
| Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S | 1 |
| Bémeur, C; Lambert, J; Montgomery, J; Ste-Marie, L; Vachon, L | 1 |
| Jameson, GN; Linert, W | 1 |
| Blarzino, C; Coccia, R; De Marco, C; Foppoli, C; Rosei, MA | 1 |
| Obata, T; Yamanaka, Y | 1 |
| Kubota, S; Obata, T; Yamanaka, Y | 1 |
| Burke, WJ; Li, SW; Lin, TS; Minteer, S | 1 |
| Iravani, MM; Jenner, P; Kashefi, K; Mander, P; Rose, S | 1 |
| Choi, SY; Kang, JH; Kang, TC; Kim, KS; Kwon, HY; Won, MH | 1 |
| Allsop, D; El-Agnaf, OM; Tabner, BJ; Turnbull, S | 1 |
10 review(s) available for hydroxyl radical and Parkinson Disease
| Article | Year |
|---|---|
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.
Topics: Alzheimer Disease; Anti-Bacterial Agents; Apoptosis; Humans; Huntington Disease; Hydrogen Peroxide; Hydroxyl Radical; Iron; Iron Chelating Agents; Ligands; Oxidative Stress; Parkinson Disease; Prion Diseases; Systems Biology | 2010 |
Peculiarities of L: -DOPA treatment of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Biological Transport; Brain Chemistry; Dopamine; Dyskinesias; Humans; Hydroxyl Radical; Levodopa; Parkinson Disease; Rats; Receptors, Dopamine | 2005 |
Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease.
Topics: Amino Acid Oxidoreductases; Animals; Free Radical Scavengers; Humans; Hydroxyl Radical; Monoamine Oxidase Inhibitors; Nitric Oxide Synthase; Oxidative Stress; Parkinson Disease | 1994 |
Hydroxyl radicals, iron, oxidative stress, and neurodegeneration.
Topics: Abetalipoproteinemia; Alzheimer Disease; Animals; Antioxidants; Brain; Brain Diseases; Brain Injuries; Brain Ischemia; Cell Membrane; Ferritins; Hemosiderin; Humans; Hydroxyl Radical; Iron; Nerve Degeneration; Oxidative Stress; Parkinson Disease | 1994 |
Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Animals; Antioxidants; Corpus Striatum; Free Radicals; Humans; Hydroxyl Radical; Lipid Peroxidation; Monoamine Oxidase; Neurons; Parkinson Disease; Rats; Selegiline; Substantia Nigra | 1994 |
In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.
Topics: Animals; Antioxidants; Basal Ganglia; Corpus Striatum; Dopamine; Free Radical Scavengers; Free Radicals; Humans; Hydroxyl Radical; Melanins; MPTP Poisoning; Nerve Degeneration; Parkinson Disease; Rats; Salicylates; Selegiline; Substantia Nigra | 1994 |
Parkinson's disease and free radicals. Mechanism of neurodegeneration and neuroprotection.
Topics: Corpus Striatum; Deferoxamine; Free Radicals; Humans; Hydroxyl Radical; Nerve Degeneration; Neurons; Parkinson Disease | 1996 |
Iron metabolism and Parkinson's disease.
Topics: Cell Death; Dopamine; Free Radicals; Humans; Hydroxyl Radical; Iron; Lactoferrin; Neurons; Parkinson Disease; Reactive Oxygen Species; Substantia Nigra; Transferrin | 1998 |
Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease.
Topics: Catecholamines; Disease Progression; Dopamine; Ferritins; Humans; Hydroxyl Radical; Iron; Neurotransmitter Agents; Oxidation-Reduction; Parkinson Disease | 2000 |
Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Cell Death; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrogen Peroxide; Hydroxyl Radical; Metals; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Synucleins | 2002 |
3 trial(s) available for hydroxyl radical and Parkinson Disease
| Article | Year |
|---|---|
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.
Topics: Aged; Cell Death; Cytoplasm; DNA; Female; Guanosine; Humans; Hydroxyl Radical; Immunohistochemistry; Male; Neurons; Oxidative Stress; Parkinson Disease; RNA; Substantia Nigra | 1999 |
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.
Topics: Antiparkinson Agents; Biomarkers; Blood Platelets; Dopamine; Female; Gentisates; Humans; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Levodopa; Linear Models; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Sodium Salicylate; Superoxide Dismutase; Tyrosine | 1999 |
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection.
Topics: Adult; Antiparkinson Agents; Blood Platelets; Chromatography, High Pressure Liquid; Electrochemistry; Female; Humans; Hydroxybenzoates; Hydroxyl Radical; Levodopa; Male; Middle Aged; Parkinson Disease; Tyrosine | 1999 |
30 other study(ies) available for hydroxyl radical and Parkinson Disease
| Article | Year |
|---|---|
Discovery of novel 2-hydroxyl-4-benzyloxybenzyl aniline derivatives as potential multifunctional agents for the treatment of Parkinson's disease.
Topics: Animals; Antioxidants; Chelating Agents; Hydroxyl Radical; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease | 2023 |
Discovery of novel 2-(4-(benzyloxy)-5-(hydroxyl) phenyl) benzothiazole derivatives as multifunctional MAO-B inhibitors for the treatment of Parkinson's disease.
Topics: Benzothiazoles; Humans; Hydroxyl Radical; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Structure-Activity Relationship | 2023 |
Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Dopaminergic Neurons; Glucose; Hydroxyl Radical; Hyperglycemia; Isoquinolines; Neurotoxins; Parkinson Disease; Rats; Tetrahydroisoquinolines | 2014 |
Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Free Radical Scavengers; Humans; Hydroxyl Radical; Hyoscyamus; Male; Medicine, Ayurvedic; Methanol; Mice; Mice, Inbred BALB C; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Parkinson Disease; Plant Extracts | 2011 |
Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian rats.
Topics: Animals; Antioxidants; Behavior, Animal; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyl Radical; Iron; Male; Mental Disorders; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |
Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Corpus Striatum; Dopamine; Dopaminergic Neurons; Glutamic Acid; Hydroxyl Radical; Inflammation; Lipopolysaccharides; Male; Microinjections; Parkinson Disease; Purines; Rats; Receptor, Adenosine A2A | 2013 |
Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Topics: alpha-Synuclein; Amino Acid Substitution; Anserine; Antioxidants; Antiparkinson Agents; Biopolymers; Carnosine; Chelating Agents; Codon; Copper; Edetic Acid; Free Radical Scavengers; Humans; Hydrogen Peroxide; Hydroxyl Radical; Isopropyl Thiogalactoside; Lewy Bodies; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Phenylmethylsulfonyl Fluoride; Point Mutation; Resins, Synthetic; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1; Synucleins; Tyrosine | 2003 |
Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biogenic Amines; Cattle; Cell-Free System; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Hydroxyl Radical; Mice; Mice, Inbred BALB C; Mitochondria; MPTP Poisoning; Neurons; Neurotoxins; Parkinson Disease; Peptides; Proline-Rich Protein Domains | 2006 |
A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synuclein.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Benzenesulfonates; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Humans; Hydroxyl Radical; Nitroso Compounds; Parkinson Disease; Peptide Fragments; Peptides; Reactive Oxygen Species; Recombinant Fusion Proteins | 2006 |
Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.
Topics: Apoptosis; Catechols; Cell Line, Tumor; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Humans; Hydroxyl Radical; Iron; Iron Metabolism Disorders; Isoquinolines; Malondialdehyde; Models, Biological; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Parkinson Disease; Salsoline Alkaloids; Up-Regulation | 2008 |
The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence.
Topics: Animals; Brain; Catalase; Catecholamines; Dopamine; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Levodopa; Monoamine Oxidase; Nerve Degeneration; Neurons; Parkinson Disease; Rats; Selegiline; Superoxide Dismutase; Superoxides | 1983 |
N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity.
Topics: Animals; Ascorbic Acid; Catalase; Chromatography, High Pressure Liquid; Dopamine; Ferric Compounds; Ferrous Compounds; Free Radicals; Glutathione; Humans; Hydroxyl Radical; Isoquinolines; Methylation; Neurons; Oxidation-Reduction; Parkinson Disease; Salsoline Alkaloids; Superoxide Dismutase; Tetrahydroisoquinolines | 1995 |
Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration.
Topics: Adenosine Diphosphate; Animals; Calcium; Cell Hypoxia; Cerebellum; Cerebral Cortex; Electron Spin Resonance Spectroscopy; Electron Transport; Free Radicals; Humans; Hydroxyl Radical; Male; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Nerve Degeneration; Neurons; Nitrogen Oxides; Parkinson Disease; Pyridines; Rats; Rats, Wistar; Sodium; Spin Labels | 1994 |
The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.
Topics: Animals; Deferoxamine; Dominance, Cerebral; Ferritins; Free Radicals; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Injections, Intraventricular; Iron; Lipid Peroxidation; Nitric Oxide; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Stereotyped Behavior; Substantia Nigra | 1993 |
Radical formation site of cerebral complex I and Parkinson's disease.
Topics: Animals; Brain; Cattle; Electrophoresis, Polyacrylamide Gel; Hydrogen-Ion Concentration; Hydroxyl Radical; Lipid Peroxidation; Mitochondria; NAD; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Paraquat; Parkinson Disease; Reactive Oxygen Species; Superoxide Dismutase; Superoxides | 1995 |
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.
Topics: Dopamine; Electron Transport; Ferric Compounds; Ferritins; Hydroxydopamines; Hydroxyl Radical; In Vitro Techniques; Kinetics; Molecular Structure; Neurotoxins; Oxidation-Reduction; Oxidopamine; Oxygen; Parkinson Disease; Spectrophotometry; Spectrophotometry, Ultraviolet | 1995 |
Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.
Topics: Animals; Antioxidants; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Free Radical Scavengers; Hydroxyl Radical; Hypochlorous Acid; Lipid Peroxidation; Liposomes; Male; Oxidants; Oxygen; Parkinson Disease; Superoxides | 1996 |
Fragile mitochondrial DNA: the missing link in the apoptotic neuronal cell death in Parkinson's disease.
Topics: Adolescent; Adult; Aged; Apoptosis; Child; Child, Preschool; Corpus Striatum; DNA Fragmentation; DNA, Mitochondrial; Female; Humans; Hydroxyl Radical; Male; Neurons; Oxidative Stress; Parkinson Disease; Particle Size; Sequence Deletion | 1997 |
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.
Topics: Aged; Aged, 80 and over; Aging; Base Composition; DNA; DNA Damage; Gas Chromatography-Mass Spectrometry; Guanine; Humans; Hydroxyl Radical; Middle Aged; Nitrates; Oxidants; Oxidation-Reduction; Parkinson Disease; Pyrimidines; Reference Values; Regression Analysis; Substantia Nigra | 1997 |
Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Stem; Corpus Striatum; Glutathione; Glutathione Disulfide; Hydroxyl Radical; Iron; Iron, Dietary; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Neurons; Parkinson Disease; Risk Factors | 1997 |
Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cysteine; Glutamic Acid; Glutathione; Glycine; Hydrolysis; Hydroxyl Radical; Iron; Kinetics; Male; Microdialysis; Mitochondria; Models, Chemical; Nitro Compounds; Oxygen Consumption; Parkinson Disease; Perfusion; Propionates; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1999 |
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data.
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors | 1999 |
Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate.
Topics: 1-Methyl-4-phenylpyridinium; Allyl Compounds; Animals; Antioxidants; Butylamines; Corpus Striatum; Dopamine; Free Radical Scavengers; Hydroxybenzoates; Hydroxyl Radical; Hydroxylation; Injections, Intraperitoneal; Male; Microdialysis; Monoamine Oxidase Inhibitors; Neurotoxins; Parabens; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |
Interaction of enkephalin derivatives with reactive oxygen species.
Topics: Animals; Enkephalins; Free Radical Scavengers; Humans; Hydroxyl Radical; In Vitro Techniques; Lipid Peroxidation; Melanins; Oxidation-Reduction; Parkinson Disease; Peroxides; Reactive Oxygen Species; Superoxides | 2001 |
Nitric oxide enhances MPP(+)-induced hydroxyl radical generation via depolarization activated nitric oxide synthase in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Allopurinol; Animals; Dopamine; Enzyme Inhibitors; Extracellular Space; Herbicides; Hydroxybenzoates; Hydroxyl Radical; Iron; Iron Chelating Agents; Male; Membrane Potentials; Microdialysis; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Parkinson Disease; Potassium; Rats; Rats, Wistar | 2001 |
Allopurinol suppresses para-nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP(+))-induced hydroxyl radical generation in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Allopurinol; Animals; Dose-Response Relationship, Drug; Drug Interactions; Free Radical Scavengers; Hazardous Substances; Hydroxyl Radical; Male; Microdialysis; Neostriatum; Nerve Degeneration; Parkinson Disease; Parkinson Disease, Secondary; Phenols; Rats; Rats, Wistar | 2001 |
3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aldehydes; Brain; Catechols; Humans; Hydrogen Peroxide; Hydroxyl Radical; Male; Nerve Degeneration; Parkinson Disease; Spectrophotometry, Atomic | 2001 |
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.
Topics: Animals; Cell Count; Cell Death; Dopamine; Encephalitis; Fluorescent Dyes; Glial Fibrillary Acidic Protein; Hydroxyl Radical; Lipopolysaccharides; Macrophages; Male; NADPH Dehydrogenase; Neurons; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |
Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Topics: alpha-Synuclein; Humans; Hydrogen Peroxide; Hydroxyl Radical; Macromolecular Substances; Nerve Tissue Proteins; Parkinson Disease; Protein Binding; Superoxide Dismutase; Synucleins | 2002 |
Monoamine oxidase, hydrogen peroxide, and Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Culture Techniques; Dopamine; Humans; Hydrogen Peroxide; Hydroxides; Hydroxydopamines; Hydroxyl Radical; Macaca fascicularis; Monoamine Oxidase; Neurons; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Superoxides | 1987 |